These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9851563)
1. Arachidonic acid release from PC12 pheochromocytoma cells is regulated by I1-imidazoline receptors. Ernsberger P J Auton Nerv Syst; 1998 Oct; 72(2-3):147-54. PubMed ID: 9851563 [TBL] [Abstract][Full Text] [Related]
2. Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Separovic D; Kester M; Ernsberger P Mol Pharmacol; 1996 Apr; 49(4):668-75. PubMed ID: 8609895 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine. Bock C; Niederhoffer N; Szabo B Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524 [TBL] [Abstract][Full Text] [Related]
4. The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK). Edwards L; Fishman D; Horowitz P; Bourbon N; Kester M; Ernsberger P J Neurochem; 2001 Dec; 79(5):931-40. PubMed ID: 11739604 [TBL] [Abstract][Full Text] [Related]
5. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Szabo B; Urban R Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413 [TBL] [Abstract][Full Text] [Related]
15. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension. Wang X; Li G; Abdel-Rahman AA Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806 [TBL] [Abstract][Full Text] [Related]
16. The imidazoline I1 receptor agonist, moxonidine, inhibits insulin secretion from isolated rat islets of Langerhans. Tsoli E; Chan SL; Morgan NG Eur J Pharmacol; 1995 Sep; 284(1-2):199-203. PubMed ID: 8549627 [TBL] [Abstract][Full Text] [Related]
17. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858 [TBL] [Abstract][Full Text] [Related]
18. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues. Molderings GJ; Likungu J; Jakschik J; Göthert M Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527 [TBL] [Abstract][Full Text] [Related]
19. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo. Sastre-Coll A; Esteban S; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334 [TBL] [Abstract][Full Text] [Related]
20. Effect of moxonidine on the uveoscleral outflow: role of alpha2-adrenoceptors or i1 imidazoline receptors. Yang J; Sun N; Xiong Q; Yang R Curr Eye Res; 2009 Apr; 34(4):287-96. PubMed ID: 19373577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]